[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337192-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337192-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","chromatin-licensing-and-dna-replication-factor-1-as-a-potential-prognostic-and-diagnostic-biomarker-for-gastric-cancer-research","Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer - Research","","Chromatin licensing and DNA replication factor 1 (CDT1) is investigated for its role in gastric cancer progression and as a potential prognostic and diagnostic biomarker. The study combines TCGA-based bioinformatics analyses with Kaplan–Meier and GEPIA outputs, immunohistochemistry validation in gastric cancer tissues, and siRNA-driven cell experiments to assess proliferation, migration, and invasion. Results show CDT1 overexpression correlates with poor prognosis and promotes EMT-related molecular changes that enhance malignant cell behaviors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/chromatin-licensing-and-dna-replication-factor-1-as-a-potential-prognostic-and-diagnostic-biomarker-for-gastric-cancer-research/337192/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/chromatin-licensing-and-dna-replication-factor-1-as-a-potential-prognostic-and-diagnostic-biomarker-for-gastric-cancer-research/337192.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research objective of this study on CDT1?","Question",{"text":63,"@type":64},"To determine CDT1’s biological function and molecular mechanism in gastric cancer, and evaluate whether CDT1 expression can serve as a prognostic and diagnostic biomarker.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was CDT1 expression assessed in gastric cancer samples?",{"text":68,"@type":64},"CDT1 expression in stomach cancer tissues was measured using immunohistochemistry, and related clinicopathological associations were examined.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional effects does CDT1 have on gastric cancer cells?",{"text":72,"@type":64},"CDT1 upregulation promotes proliferation and invasion, supported by siRNA and cell functional experiments in gastric cancer cell lines, along with EMT-related marker changes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337192,1790812378,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nChromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer  \nSijia Wang1, Min Cui2, Na Zhou3, Meichen Tong3, Shuhua Wu3, Hong Li3􀀍 & Zhang Cao1,3􀀍  \nAccurate and timely genetic material replication is essential for preserving genomic integrity. The replication process begins with chromatin licensing and DNA replication factor 1 (CDT1) . It has been demonstrated that dysregulated CDT1 expression causes genomic instability, damages DNA, and may even cause cancer. Although this protein is overexpressed in several malignancies, its significance in gastric cancer is still unknown. This work aims to investigate the biological function and molecular mechanism of CDT1 in gastric cancer. Bioinformatics studies were carried out using TCGA database, Kaplan–Meier and GEPIA online data analysis software. The expression of CDT1 in stomach cancer tissues was determined by immunohistochemistry, and its relationship to clinicopathological features was examined. Using siRNA and cell function experiments, the impact of CDT1 expression on the capacity of gastric cancer cell lines to proliferate, migrate, and invade was investigated. In gastric cancer tissues, CDT1 is overexpressed and is linked to a dismal prognosis. Through the up-regulation of M-cyc, MCM5 (microchromosome maintenance protein 5), CyclinD1, N-cadherin, and the downregulation of E-cadherin, CDT1 facilitated the proliferation and invasion of gastric cancer cells. The study’s findings shed insight on the possible molecular processes behind CDT1’s function in promoting the start and progression of gastric cancer and demonstrate the potential predictive and diagnostic use of CDT1 expression in gastric cancer.  \nKeywords Gastric cancer, CDT1, Proliferation, Invasion, EMT  \nGastric cancer is the third most common cause of cancer-related death worldwide and the fifth most common type of cancer overall1. Among the main risk factors for gastric cancer are Helicobacter pylori infection, advanced age, excessive salt use, and poor dietary habits2. Due to infrequent routine screenings and mild symptoms in the early stages, the majority of individuals receive their diagnosis at an advanced level. Currently, perioperative chemotherapy is the standard treatment for resectable gastric cancer. Ongoing studies, however, are looking atthe possible advantages of immunotherapy and targeted therapy in adjuvant and perioperative settings3. For example, AFF3 may influence immune checkpoint inhibitors (ICIs) by affecting TIICs and immune checkpoint (IC) expression in the tumor microenvironment (TME), which might be an excellent prospective marker for gastric cancer patients’ diagnosis and prognosis4. Furthermore, ZBTB20 stimulated NF-κB signaling in gastric cancer cells, causing phosphorylation of NF-κBp65 as well as stimulation of the synthesis and function of MMP- 2 and MMP-9, hence facilitating the movement, infiltration, and multiplication of cells5.  \nThe exact time of DNA replication is essential to maintaining genomic integrity. The replication starts, also known as the initial stage of eukaryotic DNA replication, takes place during G1 and involves the progressive loading of replication components at different genomic sites6. Pre-replication complexes (pre-RCs) are chromatin-bound macromolecular complexes that are assembled from core licensing factors. The pre-RCs comprise the origin recognition complex (ORC), cell division cycle 6 (Cdc6), minichromosome maintenance  \n(MCM), and CDT1 . DNA replication is restricted to one cycle per cell by CDT1, which loads the MCM2-7 deconjugated complex solely onto chromatin in the G1 phase of the cell cycle7. If an error in DNA replication or an endogenous or exogenous factor causes DNA damage, it must be sensed and repaired quickly. As a result, cellular proteins constantly scan the DNA to recognize the damaged site and recr","cbCaickFUHrYQjZM","https://ap.wps.com/l/cbCaickFUHrYQjZM","pdf",3325070,12,"English","# Materials and methods\n## Cell lines and culture conditions","[{\"question\":\"What is the main research objective of this study on CDT1?\",\"answer\":\"To determine CDT1’s biological function and molecular mechanism in gastric cancer, and evaluate whether CDT1 expression can serve as a prognostic and diagnostic biomarker.\"},{\"question\":\"How was CDT1 expression assessed in gastric cancer samples?\",\"answer\":\"CDT1 expression in stomach cancer tissues was measured using immunohistochemistry, and related clinicopathological associations were examined.\"},{\"question\":\"What functional effects does CDT1 have on gastric cancer cells?\",\"answer\":\"CDT1 upregulation promotes proliferation and invasion, supported by siRNA and cell functional experiments in gastric cancer cell lines, along with EMT-related marker changes.\"}]","Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer - Research | PDF",1790018069,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebc43964396c09aa30347520954c4f12.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/820dc1ecb102a3d648737009e4522949.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38640e36f5f0b75c94b5c2e86081f9e7.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b2c1a3a7b9e7e2472c1cbdcb680aa9d.webp",980,1287]